𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Phase I trial of high-dose infusional hydroxyurea, high-dose infusional 5-fluorouracil and recombinant interferon-α-2a in patients with advanced malignancies

✍ Scribed by Scott Wadler; Hilda Haynes; Richard Schechner; Alla Rozenblit; Peter H. Wiemik

Publisher
Springer US
Year
1995
Tongue
English
Weight
547 KB
Volume
13
Category
Article
ISSN
0167-6997

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Prolonged administration of low dose inf
Prolonged administration of low dose infusional etoposide in patients with advanced malignancies. A phase I/II study
✍ Dana S. Thompson; John D. Hainsworth; Kenneth R. Hande; Mary Holzmer; F. Anthony 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 738 KB

## Background: Etoposide displays remarkable schedule dependency. to better define the optimal dose and schedule, the authors administered etoposide as a prolonged low daily dose infusion in patients with a variety of advanced malignancies. ## Methods: Between october 1989 and april 1992, 40 pati

5-fluorouracil and low-dose recombinant
5-fluorouracil and low-dose recombinant interferon-α-2a in patients with hormone-refractory adenocarcinoma of the prostate
✍ Shinohara, Nobuo; Demura, Takayoshi; Matsumura, Kin-ya; Toyoda, Ken-ichi; Kashiw 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 58 KB 👁 1 views

## Background: The effectiveness of a chemotherapy regimen including 5-fluorouracil (5-fu) and recombinant interferon-alpha-2a (rifn-alpha-2a) was evaluated in hormone-refractory prostate cancer patients. ## Methods: Patients received a continuous intravenous infusion of 5-fu at 600 mg/m2/day for